Skip to main content
Berry Genomics Co.,Ltd logo

Berry Genomics Co.,Ltd — Investor Relations & Filings

Ticker · 000710 ISIN · CNE000000PN7 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,009 across all filing types
Latest filing 2021-07-12 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000710

About Berry Genomics Co.,Ltd

https://www.berrygenomics.com

Berry Genomics Co.,Ltd. is a biotechnology enterprise specializing in clinical genomics and genetic testing services. The company focuses on the research, development, and commercialization of genomic technologies for clinical applications. Its core portfolio includes non-invasive prenatal testing (NIPT), utilizing high-throughput sequencing to screen for chromosomal abnormalities. Beyond reproductive health, the company provides genomic solutions for oncology diagnostics, including early cancer screening and companion diagnostics, as well as testing for hereditary diseases. Berry Genomics leverages advanced sequencing platforms and proprietary bioinformatics pipelines to deliver precision medicine tools to healthcare providers and research institutions. The company is recognized for its role in the clinical application of Next-Generation Sequencing (NGS) and its extensive genomic databases used to enhance diagnostic accuracy and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
上会会计师事务所关于对成都市贝瑞和康基因技术股份有限公司的2020年年报问询函的回复
Regulatory Filings
2021-07-12 Chinese
关于放弃子公司增资扩股优先认缴权暨关联交易的公告之更正公告
Capital/Financing Update Classification · 95% confidence The document is a correction announcement related to a previous announcement about the waiver of preferential subscription rights in a subsidiary's capital increase and related party transaction. It corrects specific financial figures in the original announcement. The document is short (792 characters) and serves to amend a prior announcement rather than presenting a full report or detailed financial data. It is an announcement about a capital/financing update related to share subscription and capital increase in a subsidiary, which fits the Capital/Financing Update (CAP) category.
2021-07-05 Chinese
关于控股股东进行股票质押回购延期购回暨部分解除质押的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the extension of stock pledge repurchase and partial release of pledge by a controlling shareholder. It details the number of shares pledged, dates of pledge and release, and the impact on shareholding percentages. There is no financial statement, earnings data, or management discussion. The document is a regulatory announcement about share pledge status and does not fit into financial reports or management reports. It is a typical regulatory filing informing the market about changes in pledged shares by major shareholders. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length is short (2902 characters), and it is not a report publication announcement or certification letter, so RNS is the best fit.
2021-07-02 Chinese
独立董事关于第九届董事会第九次会议相关事项的事前认可意见和独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' pre-approval and independent opinion on specific board meeting agenda items related to a transaction involving a subsidiary's capital increase and related party agreements. It references compliance with company law, stock exchange listing rules, and governance guidelines. The content focuses on board-level approval and opinions rather than financial results or detailed financial statements. The document length is short (889 characters) and it is not a full financial report or earnings release. It is not a regulatory announcement of a report publication but a governance-related opinion document. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or decisions by the board or senior management.
2021-07-02 Chinese
关于放弃子公司增资扩股优先认缴权暨关联交易的公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding a corporate transaction involving the waiver of a subsidiary's capital increase subscription rights and related party transactions. It includes extensive information about shareholders, shareholding percentages, board meeting resolutions, and related party relationships. There is no indication that this is a financial report such as an annual or interim report, nor is it a transcript, audit report, or earnings release. The document is a formal announcement of a corporate transaction and related party disclosures, consistent with regulatory disclosure requirements for listed companies. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2021-07-02 Chinese
关于第一期员工持股计划非交易过户完成的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the completion of a non-trade transfer of shares under the company's first employee stock ownership plan. It details the stock source, subscription, transfer, related party relationships, and accounting treatment of the plan. The document is relatively short (3022 characters) and primarily serves to inform shareholders and the public about the progress and completion of a specific employee stock plan transfer. It does not contain comprehensive financial statements or detailed financial performance data. It is not a full financial report like an Annual Report (10-K) or Interim Report (IR), nor is it a regulatory certification or a proxy solicitation. The content fits best with a Regulatory Filing (RNS) as it is a formal disclosure of a corporate action related to employee stock plans without constituting a full report or detailed financial supplement.
2021-07-02 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.